Reducing the risk of perinatal HIV-1 transmission with zidovudine: results and implications of AIDS Clinical Trials Group protocol 076.

作者: LM Mofenson

DOI: 10.1111/J.1651-2227.1997.TB18328.X

关键词:

摘要: This paper reviews the rationale for AIDS Clinical Trials Group (ACTG) protocol 076 design, study results and implications of these results, including discussion US Public Health Service Task Force recommendations on use zidovudine to reduce perinatal transmission prenatal human immunodeficiency virus (HIV) counseling testing.

参考文章(30)
K M Ayers, Preclinical toxicology of zidovudine. An overview. The American Journal of Medicine. ,vol. 85, pp. 186- 188 ,(1988)
James W. Buehler, Susan Y. Chu, Barbara W. Kilbourne, Margaret J. Oxtoby, Impact of the human immunodeficiency virus epidemic on mortality in children, United States. Pediatrics. ,vol. 87, pp. 806- 810 ,(1991)
Kathie A. Contello, Coleen K. Cunningham, Kim Kirkwood, Timothy D. Dye, Leonard B. Weiner, James Coplan, Failure to Identify Human Immunodeficiency Virus-Seropositive Newborns: Epidemiology and Enrollment Patterns in a Predominantly White, Nonurban Setting Pediatrics. ,vol. 96, pp. 1083- 1089 ,(1995)
Michael J. Domanski, M.Melisse Sloas, Dean A. Follmann, Peter P. Scalise, Eben E. Tucker, Debra Egan, Philip A. Pizzo, Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus The Journal of Pediatrics. ,vol. 127, pp. 137- 146 ,(1995) , 10.1016/S0022-3476(95)70275-X
Angus Nicoll, Marie-Louise Newell, Eric Van Praag, Philippe Van de Perre, Catherine Peckham, Infant feeding policy and practice in the presence of HIV-1 infection. AIDS. ,vol. 9, pp. 107- 120 ,(1995) , 10.1097/00002030-199502000-00001
Mary J O'Sullivan, Pamela JJ Boyer, Gwendolyn B Scott, Wade P Parks, Stephen Weller, M Robert Blum, James Balsley, Yvonne J Bryson, Zidovudine Collaborative Working Group, The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group study (protocol 082) American Journal of Obstetrics and Gynecology. ,vol. 168, pp. 1510- 1516 ,(1993) , 10.1016/S0002-9378(11)90791-1
A. Erice, H. H. Balfour, Resistance of Human Immunodeficiency Virus Type 1 to Antiretroviral Agents: A Review Clinical Infectious Diseases. ,vol. 18, pp. 149- 156 ,(1994) , 10.1093/CLINIDS/18.2.149
M. Barbacci, R.E. Chaisson, J.T. Repke, Routine prenatal screening for HIV infection The Lancet. ,vol. 337, pp. 709- 711 ,(1991) , 10.1016/0140-6736(91)90286-X
Susan F Davis, Robert H Byers, Mary Lou Lindegren, M Blake Caldwell, John M Karon, Marta Gwinn, Prevalence and Incidence of Vertically Acquired HIV Infection in the United States JAMA: The Journal of the American Medical Association. ,vol. 274, pp. 952- 955 ,(1995) , 10.1001/JAMA.1995.03530120044039